The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
The Enterprise Europe Network (EEN), in partnership with Innovate UK is organising a funded Accelerator Programme visit to Japan for innovative UK companies operating in the Cell and Gene Therapy sector.
Read the rest of entry »
Arecor and its partner, non-profit company, Global Alliance for Livestock Veterinary Medicines (GALVmed), have successfully stabilised liquid formulations of vaccines to combat two major diseases of livestock across the developing world including Africa, Asia and the Middle East
In this work, the ArestatTM technology has been applied to enable a vaccine to be distributed pre-prepared in a liquid format without the requirement for in-field reconstitution from the freeze-dried powder form
ArestatTM technology has also been applied to reduce the cost of a batch of vaccine diluent by 96 per cent., thereby improving its distribution and uptake by farmers
Arecor’s formulation technology work has been supported by Innovate UK through UK aid of the UK government and the Bill & Melinda Gates Foundation
Cambridge, UK., 8th December 2017: Arecor Ltd (“the Company”), a leader in developing superior biopharmaceuticals through the application of an innovative formulation technology ...
For the full news article, please see http://www.bbc.co.uk/news/in-pictures-40582699
Leadership in place; Clinical Operations teams growing throughout Europe
BETHESDA, Md., July 6, 2017 /PRNewswire/ -- Precision for Medicine today reported important progress in its global expansion plan. Precision for Medicine, with its oncology research team Precision Oncology, is rapidly expanding its global footprint to better serve clients developing oncology treatments. Investment in executive leadership and operational teams are underway across Europe, providing integrated, full-service clinical trial execution services throughout the continent.
Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce it has entered into a strategic drug discovery collaboration with GlaxoSmithKline (GSK). During this collaboration, Exscientia will apply its AI enabled platform and combine this with the expertise of GSK, in order to discover novel and selective small molecules for up to 10 disease-related targets, nominated by GSK across multiple therapeutic areas.
Upon implementation of the new reimbursement codes, which is expected in the next 21 days, the French Ministry of Health and Social Affairs will provide reimbursement
The minister of state for universities, science, research and innovation, Jo Johnson MP, visited The Oxford Science Park (“the Park”) on Tuesday 4 April 2017 to take part in an official ground-breaking ceremony and reveal the name of the £13 million state of the art new office and laboratory building capable of accommodating 500 people.
The latest figures, the deepest insights, the most comprehensive expertise.
The NIHR Brain Injury Healthcare Technology Co-operative is pleased to announce the second round of its second national competition. The seed funding call (up to £10,000) is for the early development of novel technology-based solutions applicable to the brain injury pathway, from prevention of injury all the way through to technologies for independent living. Applications are invited from academic institutions, NHS Trusts, third sector organisations and SME’s.
London, UK - Tests including an ultrasonic hologram and treatments for serious conditions, such as hospital superbugs, are the latest projects to win a share of Government funding. Sixty seven projects will win a share of £26 million funding available through Biomedical Catalyst 2016, which is run by Innovate UK and the Medical Research Council, and aims to develop innovative healthcare technologies and processes.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, firstname.lastname@example.org, and we will post.